Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and Metformin in Healthy Adults: Fed State Study [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and pharmacokinetics of a triple combination of dapagliflozin, linagliptin, and metformin in healthy adults under fed conditions…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Linagliptin (linagliptin)
• metformin (metformin)

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Type2 Diabetes Mellitus | Phase 1 | Status: NOT_YET_RECRUITING